NEW YORK, NY / ACCESSWIRE / September 29, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sema4 Holdings Corp. (“Sema4” or the “Company”) (NASDAQ:SMFR) and reminds investors of the November 7, 2022 deadline to file the lawsuit as lead plaintiff in a state securities class action lawsuit filed against the Company.

If you suffered losses of more than $100,000 between March 14, 2022 and August 15, 2022 investing in Sema4 stocks or options and discuss your legal rights, call Faruqi & Faruqi Partner Josh Wilson direct at 877-247-4292 or 212-983-9330 (ext. 1310). You can also click here for more information: www.faruqilaw.com/SMFR.

There are no costs or obligations for you.

Faruqi & Faruqi is a leading national minority and women-owned securities firm with offices in New York, Pennsylvania, California and Georgia.

As detailed below, the Complaint focuses on whether the Company and its officers violated federal securities laws by making false and/or misleading statements and/or failing to disclose: (1) that there was a significant risk that Sema4 reverse a substantial amount of previously recognized revenue that it was unable to recover from third-party payers; (2) that the company experienced decreasing selling prices for its reproductive health segment; (3) that Sema4’s financial results would be adversely affected as a result of the foregoing; and (4) that as a result of the foregoing, defendants’ positive statements about the Company’s business, operations and prospects were materially misleading and/or lacked any reasonable basis.

On August 15, 2022, after the market closed, Sema4 announced changes to its R&D leadership team, including the resignation of defendant Schadt from his roles as President and Chief R&D Officer. The company also announced that as part of a series of…